President of TecSalud
San Pedro Garza Garcia, Nuevo Leon, Mexico
Dr. Guillermo Torre Amione is the President of TecSalud and Vice President of Research, Tecnológico de Monterrey; Chairman of Cardiovascular Research at TecSalud School of Medicine Tecnológico de Monterrey. He is one of the founders of the Transplant Laboratory at Houston Methodist Hospital and was a board member of the DeBakey Heart Center run by Houston Methodist Hospital and the University of St. Thomas.
He holds a medical degree from Tecnológico de Monterrey, with a fellowship in Internal
Medicine and in Interventional Cardiology, Heart Failure, and Transplantation from Baylor
College of Medicine, and a PhD in Immunology from the University of Chicago.
Guillermo Torre is a Level 3 member of the Mexican National Research System. His
primary research interest has been in pathophysiological basis of heart failure, with
particular emphasis in immune regulation.
Dr. Torre has published more than 200 scientific articles with more than 12,000 citations
(H-index 56), winning the SCOPUS award for the country's most cited author. He has
published five books and three patents.
He is a member of the Mexican Academy of Medicine, the American College of Cardiology,
and the American Heart Association; he is certified as a specialist in Clinical Cardiology by
the Mexican Council of Cardiology and certified in Internal Medicine, Cardiology, Heart
Failure, and Transplantation by the American Board of Internal Medicine.
He is founder of the technology-based health company Nano4Heart and a President of the
board of Cardiol Therapeutics a company dedicated to the development of drugs for the
treatment of heart failure.
Disclosure information not submitted.
New Targets: Isatroxime in Cardiogenic Shock
Friday, March 6, 2026
11:15 AM - 11:22 AM CST